Items tagged with Drug-resistant TB

DR-TB STAT: September 2016 summary and updates (post with simple image)

The DR-TB Scale-Up Treatment Action Team (DR-TB STAT) released its September 2016 update informing about the general progress in the introduction of bedaquiline and delamanid in TB programs worldwide.

Advocates call for the Ministry of Health in Peru to facilitate access to delamanid (post with simple image)

TB advocates encourage the Ministry of Health in Peru to develop country guidance on the use of delamanid for the treatment of drug-resistant TB, a first step to facilitating access.

Breakthrough study demonstrates far shorter, more effective treatment for MDR-TB, with majority cured (post with simple image)

Final results demonstrated nine-month treatment had 82% success rate, compared with previous standard that required more than 20 months of treatment and achieved cure rates below 55%.

Urgent action required to end bureaucratic delays and expedite enrollment of the NExT study (post with simple image)

TB advocates addressed the University of Limpopo and Sefako Makgatho Health Science University demanding the immediate release of funds for the NeXT study.

Unknown unknowns: poverty and tuberculosis in Romania (post with simple image)

Mircea,[1] a former miner in his fifties, spent the last four years of his life succumbing to Extensively Drug Resistant Tuberculosis (XDR-TB)[2] at the Pines Tuberculosis Sanatorium, which is located high on a mountain. After seven years with this otherwise curable illness, his family wanted little to do with him. He was one of the many patients who doctors in Romania refer to as “social cases”[3] [4]According to Dr. Ionescu at the Pines, patients like Mircea are “repeat clients” with “no chance of escape.” They are people with overlapping social and economic difficulties, such as poverty, homelessness, alcohol use, lack of family support, as well as the social stigma that comes with having TB in Romania.

MSF calls on Johnson & Johnson to improve access to bedaquiline (post with simple image)

Médecins Sans Frontières (MSF) urges Johnson & Johnson to ensure widespread access to bedaquiline for the treatment of multidrug-resistant TB.

Advocates call for the Philippines Food and Drug Administration to register delamanid (post with simple image)

TB advocates encourage the Philippines Food and Drug Administration to approve delamanid, an important treatment option for people with multidrug-resistant TB.

Advocates encourage prioritization of drug-resistant TB research (post with simple image)

TB advocates encourage the Global Antimicrobial Resistance Innovation Fund to prioritize research and development for drug-resistant TB.

Advocates call on the Indian Prime Minister to ensure availability of new TB drugs to combat drug-resistant TB (post with simple image)

Advocates urge Prime Minister Modi to take immediate action to save a young woman, dying of XDR-TB and to roll out life-saving innovations to tackle the growing burden of drug-resistant TB in India.

Health groups call on Indian Government to urgently make life-saving TB drug available (post with simple image)

Health groups call on the Indian Government to incorporate the life-saving TB drug delamanid into the Revised National TB Control Programme.

Page 59 of 60 · Total posts: 0

←First 58 59 60 Last→